Also noteworthy, immunohistochemical staining revealed that CTCFL expression was frequently detected in GBM specimens but was completely negative in all less aggressive astrocytomas (Grade I, II or III) cases. Here, CTCFL is linked to astrocytoma (excluding glioblastoma).